Sign in now to see personalised content appear here.

You can also see your reading history and subscription details on your subscriber page.

Why subscribe?
Find out more.

Sign up for your FREE email newsletter  +


Aston University to tackle multidrug resistance targets in collaboration with Calixar

They will study the extraction, stabilisation and crystallisation of full-length human ABC transporters

Europe | R and D | Therapeutic Sector

ATCC adds new customer-driven format to its quality control standards portfolio

Makes it easier for industrial and pharmaceutical labs to test for product safety

North America | Regulatory | Measurement and Analysis

Employing new single-use technology in bioprocesses

There has been considerable progress in the application of single-use technologies in biopharmaceutical production. CMO Rentschler Biotechnologie discusses recent advances

Europe | Biotechnology | Manufacturing

Ashland opens new drug development centre of excellence in Wilmington, US

Increases its pharmaceutical technologies capabilities to address global drug development and bioavailability enhancement trends

North America | Drug Delivery | R and D | Manufacturing

Lyophilisation: meeting new demand and challenges

Armin Dalluege, General Manager of Wasserburger Arzneimittelwerk, a subsidiary of Recipharm, in Wasserburg, Germany, highlights trends in drug lyophilisation


FOYA projects enhanced with GEA Technology

The company supplies equipment to three winners at the ISPE awards

Europe | Manufacturing

The growth of mPEG technology

With an increase in the number of innovator companies looking to outsource the development and manufacture of mPEGs, Dr. Reddy’s (CPS) discusses what to look for in a potential outsourcing partner

Drug Delivery | R and D | Biotechnology | Manufacturing

Lilly to close one of three of its manufacturing operations in Puerto Rico

Will cease manufacturing at Guayama while investment continues at two plants in Carolina

Finance | Manufacturing

Cloud-based eTMFs – less paper, more value

With regulatory pressure mounting, pharma companies should need no help deciding to migrate to paperless trial master files. For those thinking about switching, Rik van Mol, Vice President of R&D Strategy, Veeva Systems, outlines the key considerations for making the transition

Information Technology

Pfizer Ireland Pharmaceuticals named overall winner in 2014 Facility of the Year Awards

The company expanded capacity by re-purposing existing manufacturing space and adding new vaccine and bioprocess suites

Design and Build | Europe | Manufacturing

Incorporating CMOs into the clinical trial supply chain

The clinical supply chain involves working with several outsourced partners. Jens Mattuschka, Vice President, CLS Worldwide Operations, Parexel International, looks at core planning to reduce the risk of failure

Regulatory | R and D | Manufacturing

In the Press